2 years ago

Kuano Secures £1.8 Million Seed Funding for Quantum AI-Powered Drug Discovery

  • Kuano, a Cambridge, UK-based drug discovery company, has raised £1.8 million in seed funding led by Mercia Ventures and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP and other angel investors

  • The company intends to use the funds for further validation of its platform for drug design, strategic partnerships, and recruitment

  • Kuano's platform combines quantum mechanics with AI to model enzymes in their dynamic state, enabling more effective drug design.

      • ProblemHealthcare

      "Designing more effective drugs to target enzymes is a complex and time-consuming process, and current methods often fail to produce successful candidates."

      Solution

      "Kuano uses a combination of quantum mechanics and AI to design innovative medicines. Their platform simulates enzymes in their dynamic state, providing a more accurate understanding of their behavior and enabling scientists to identify the best drug targets."

      Covered on